T
TubeFolio
Back to Dashboard

Down 40% in 2026, Is it Time to Buy Oracle Stock on the Dip? | ORCL Stock Analysis

Summary

Parkev provides an analysis of Oracle following its October 2026 investor day, where management set ambitious goals including over $30 billion in free cash flow by FY2029 and operating margins above 40% by FY2030. Parkev notes a rare market anomaly where Wall Street analysts are aggressively raising earnings-per-share growth estimates to 30%, while the stock's valuation remains low at a forward P/E of 10. Despite the company's significant debt load of $165 billion used to fund data center expansion, Parkev believes the growth prospects outweigh the balance sheet risks.

ORCL: Parkev considers Oracle significantly undervalued, calculating a fair value of $167 per share compared to the current market price of $112. He mentions that the stock is currently trading near its 52-week low of $109, which presents an attractive entry point for long-term investors. Parkev upgraded his conviction level from low to medium, noting that even his conservative free cash flow estimate of $17.5 billion for 2029 supports a higher valuation than the current market price.
NVDA: Parkev mentions Nvidia as a pivotal player in the AI industry whose upcoming earnings report on November 17 will provide crucial market data. He does not provide a specific price target for Nvidia but emphasizes its role as a bellwether for the sector's health. Parkev plans to host a live exclusive event for channel members to analyze Nvidia's quarterly results and their implications for AI-related stocks like Oracle.

Mentioned Stocks

NVDA
Sentiment: HOLD

Reasoning: Parkev mentions Nvidia primarily as a macro indicator for the AI sector. He is waiting for their quarterly results on November 17 to better understand industry trends but does not issue a specific buy or sell recommendation in this transcript.

Loading chart...
ORCL
Sentiment: BUYAction: RECOMMENDED

Reasoning: Parkev calculates a fair value of $167, which is substantially higher than the current market price of $112. He points out that the stock is trading at a low forward P/E of 10 despite analysts raising EPS growth estimates to 30%. Parkev mentions that the stock is near its 52-week low of $109 and believes that even with his conservative projections, the stock is a bargain.

Loading chart...